Why the study?
Does NP-59 adrenal scintigraphy accurately distinguish benign from malignant euadrenal masses in patients with incidentally discovered unilateral euadrenal masses?
Does NP-59 adrenal scintigraphy accurately distinguish benign from malignant euadrenal masses in patients with incidentally discovered unilateral euadrenal masses?
Functional NP-59 scintigraphy can accurately and noninvasively characterize euadrenal masses, with concordance between CT and NP-59 scans effectively excluding malignancy.
Authors
No takes yet. Share an insight, caveat, or question.
Supports noninvasive euadrenal mass characterization; leaves open prospective validation before clinical adoption.
Gross et al. (1988) studied this question.